A Randomized, Double-blind, Phase 2, Dose-finding Trial of Once Weekly Petrelintide Compared With Placebo in Participants With Obesity or Overweight With Weight Related Comorbidities
This study is testing an experimental medication called petrelintide to see how well it helps people lose weight and how safe it is compared to a placebo. Researchers want to find the best dose to help adults manage their weight and improve their overall health.
You might be eligible if you are an adult with a higher body mass index, or a BMI of 27 or higher along with a health condition like high blood pressure or abnormal cholesterol. Participants cannot have diabetes, take blood sugar medications, or have used other weight loss products recently.
During the study, you will receive either the study drug or an inactive placebo as a weekly injection that you give to yourself using a small syringe. The medical team will closely monitor your weight, health, and how well you tolerate the medication.
This completed study took place at research locations in Birmingham, Alabama, as well as Boca Raton and Clearwater, Florida. It has finished collecting its data.
- 1Testing petrelintide for weight management compared to a placebo
- 2Involves taking weekly injections yourself using a small syringe
- 3Designed for adults with high BMI and related health conditions but no diabetes
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.